Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 11Recruiting 10Active not recruiting 4Terminated 3Withdrawn 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 1CNS 1

Conditions

Lung Neoplasms 4Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Depression 2Vulvar Neoplasms 1Vomiting 1Stomach Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Neuroblastoma 1Nausea 1Leukemia 1Laryngeal Diseases 1Hematologic Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

Trastuzumab 77Capecitabine 59Cyclophosphamide 54Paclitaxel 51Docetaxel 49Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 25exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Everolimus 17Taxes 16Epirubicin 15Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13pertuzumab 12palbociclib 12liposomal doxorubicin 11Magnetic Resonance Spectroscopy 11Filgrastim 11Cisplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Interviews as Topic × Clear all
NCT01780064 2026-03-18

APAPI

Centre Oscar Lambret

Phase NA Terminated
128 enrolled
Breast

Breast Neoplasms

NCT06315296 2026-03-03

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Thomas Jefferson University

Phase NA Terminated
1 enrolled
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT04142476 2025-02-17

HORMONOVILLE

Centre Georges Francois Leclerc

Phase NA Terminated
105 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡